TTrialPathMatch Me to Trials
← Back to trials
RecruitingObesityOverweight

Home Self-administration of Maridebart Cafraglutide With Autoinjector in Adults Living With Obesity or Overweight

Eligible age

18–99 yrs

Accepts

All genders

Locations

12 states

Healthy volunteers

No

See if you qualify for this study

Answer a few quick questions about your location and health. Takes about a minute.

Check my eligibility →

About this study

The main objective of this study is to assess participants' ability to self-administer subcutaneous doses of maridebart cafraglutide at home using an autoinjector device.

Sponsor: Amgen

You may qualify if…

  • ✓ Body mass index (BMI) ≥ 30 kilograms per meter square (kg/m\^2), or BMI ≥ 27 to \< 30 kg/m\^2 with one of the following:
  • ✓ hypertension: treated, or with systolic blood pressure ≥ 130 millimeters of mercury (mmHg) or diastolic blood pressure ≥ 80 mmHg
  • ✓ dyslipidemia: treated or previously diagnosed high cholesterol, high triglycerides, or low HDL cholesterol.
  • ✓ history of obstructive sleep apnea
  • ✓ history of cardiovascular disease
  • ✓ history of fatty liver disease (including metabolic dysfunction-associated steatotic liver disease \[MASLD\] or metabolic dysfunction-associated steatohepatitis \[MASH\])
  • ✓ At least 1 unsuccessful attempt at weight loss by diet and exercise.
  • ✓ Contraception for females.

You may not qualify if…

  • ✕ Obesity induced by other endocrinologic disorders.
  • ✕ Change in body weight \> 5 kg within last 90 days.
  • ✕ Previous or planned surgical, endoscopic, or device-based treatment for obesity.
  • ✕ History of malignancy within the past 5 years.
  • ✕ Type 1 or Type 2 diabetes mellitus.
  • ✕ History of chronic pancreatitis or history of acute pancreatitis within last 180 days.
  • ✕ Family or personal history of medullary thyroid cancer.
  • ✕ Previous participation in a Maridebart Cafraglutide trial.

Where it's recruiting

California

San Diego

Florida

Miami · Orlando · The Villages

Georgia

Johns Creek · Woodstock

Idaho

Meridian

Illinois

Oak Brook

New York

Rochester

North Carolina

Morehead City

Ohio

Columbus

Oklahoma

Chickasha

South Carolina

Greenville

Texas

Dallas · Denison · DeSoto · Houston …

Source: ClinicalTrials.gov · NCT07871409 · last updated 2026-11-09

Home Self-administration of Maridebart Cafraglutide With Autoinjector · TrialPath